Loading…
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistanc...
Saved in:
Published in: | Oncotarget 2015-02, Vol.6 (6), p.3519-3530 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53 |
---|---|
cites | cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53 |
container_end_page | 3530 |
container_issue | 6 |
container_start_page | 3519 |
container_title | Oncotarget |
container_volume | 6 |
creator | Williams, Michelle M Cook, Rebecca S |
description | Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing. |
doi_str_mv | 10.18632/oncotarget.2792 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4414133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1664777881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtVArWC3ce6p85BKIP2I7PYDaFVAkKi70bDnOZNdVYgfbWYl_3yxLYTvSaEaa99486SH0hZQXRAlGL4O3IZu4hnxBZU2P0ILUvC5oVbFPB_sJOkvpTzlXxaWi9TE6oZVUnCu6QP6H7QuKOzO4_gWPMWRwPmHncRPBpIxb2EIfxgF8xsa32BpvIX7DNkx9i3_NbIL3Jpxf47CFaMMAOG8gmhGm7CyOkFzKO971KfrcmT7B2dtcot-3N0-rn8XD49396vtDYbmguehUWQlhm7JrLFdGMWC1bJVUjLRd2UDTWkUF66paiVI2QrC5oaFEghDKVmyJrva649QM0NrZfTS9HqMbTHzRwTj9_8W7jV6HreaccMLYLHD-JhDD8wQp68ElC31vPIQpaSIEl1IqRWZouYfaGFKK0L2_IaV-TUp_JKV3Sc2Ur4f23gn_cmF_AXdGlEc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664777881</pqid></control><display><type>article</type><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><source>NCBI_PubMed Central(免费)</source><creator>Williams, Michelle M ; Cook, Rebecca S</creator><creatorcontrib>Williams, Michelle M ; Cook, Rebecca S</creatorcontrib><description>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.2792</identifier><identifier>PMID: 25784482</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Animals ; Apoptosis - physiology ; Breast - cytology ; Breast - growth & development ; Breast - metabolism ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Female ; Humans ; Mammary Glands, Animal - cytology ; Mammary Glands, Animal - growth & development ; Mammary Glands, Animal - metabolism ; Myeloid Cell Leukemia Sequence 1 Protein - genetics ; Myeloid Cell Leukemia Sequence 1 Protein - metabolism ; Myeloid Cell Leukemia Sequence 1 Protein - physiology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Proto-Oncogene Proteins c-bcl-2 - physiology ; Review</subject><ispartof>Oncotarget, 2015-02, Vol.6 (6), p.3519-3530</ispartof><rights>Copyright: © 2015 Williams & Cook 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</citedby><cites>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414133/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414133/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25784482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Michelle M</creatorcontrib><creatorcontrib>Cook, Rebecca S</creatorcontrib><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</description><subject>Animals</subject><subject>Apoptosis - physiology</subject><subject>Breast - cytology</subject><subject>Breast - growth & development</subject><subject>Breast - metabolism</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Mammary Glands, Animal - cytology</subject><subject>Mammary Glands, Animal - growth & development</subject><subject>Mammary Glands, Animal - metabolism</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - genetics</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - physiology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - physiology</subject><subject>Review</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUU1P3DAQtVArWC3ce6p85BKIP2I7PYDaFVAkKi70bDnOZNdVYgfbWYl_3yxLYTvSaEaa99486SH0hZQXRAlGL4O3IZu4hnxBZU2P0ILUvC5oVbFPB_sJOkvpTzlXxaWi9TE6oZVUnCu6QP6H7QuKOzO4_gWPMWRwPmHncRPBpIxb2EIfxgF8xsa32BpvIX7DNkx9i3_NbIL3Jpxf47CFaMMAOG8gmhGm7CyOkFzKO971KfrcmT7B2dtcot-3N0-rn8XD49396vtDYbmguehUWQlhm7JrLFdGMWC1bJVUjLRd2UDTWkUF66paiVI2QrC5oaFEghDKVmyJrva649QM0NrZfTS9HqMbTHzRwTj9_8W7jV6HreaccMLYLHD-JhDD8wQp68ElC31vPIQpaSIEl1IqRWZouYfaGFKK0L2_IaV-TUp_JKV3Sc2Ur4f23gn_cmF_AXdGlEc</recordid><startdate>20150228</startdate><enddate>20150228</enddate><creator>Williams, Michelle M</creator><creator>Cook, Rebecca S</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150228</creationdate><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><author>Williams, Michelle M ; Cook, Rebecca S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Apoptosis - physiology</topic><topic>Breast - cytology</topic><topic>Breast - growth & development</topic><topic>Breast - metabolism</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Mammary Glands, Animal - cytology</topic><topic>Mammary Glands, Animal - growth & development</topic><topic>Mammary Glands, Animal - metabolism</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - genetics</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - physiology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - physiology</topic><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Williams, Michelle M</creatorcontrib><creatorcontrib>Cook, Rebecca S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Michelle M</au><au>Cook, Rebecca S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2015-02-28</date><risdate>2015</risdate><volume>6</volume><issue>6</issue><spage>3519</spage><epage>3530</epage><pages>3519-3530</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>25784482</pmid><doi>10.18632/oncotarget.2792</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2015-02, Vol.6 (6), p.3519-3530 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4414133 |
source | NCBI_PubMed Central(免费) |
subjects | Animals Apoptosis - physiology Breast - cytology Breast - growth & development Breast - metabolism Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - pathology Female Humans Mammary Glands, Animal - cytology Mammary Glands, Animal - growth & development Mammary Glands, Animal - metabolism Myeloid Cell Leukemia Sequence 1 Protein - genetics Myeloid Cell Leukemia Sequence 1 Protein - metabolism Myeloid Cell Leukemia Sequence 1 Protein - physiology Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism Proto-Oncogene Proteins c-bcl-2 - physiology Review |
title | Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A28%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bcl-2%20family%20proteins%20in%20breast%20development%20and%20cancer:%20could%20Mcl-1%20targeting%20overcome%20therapeutic%20resistance?&rft.jtitle=Oncotarget&rft.au=Williams,%20Michelle%20M&rft.date=2015-02-28&rft.volume=6&rft.issue=6&rft.spage=3519&rft.epage=3530&rft.pages=3519-3530&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.2792&rft_dat=%3Cproquest_pubme%3E1664777881%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664777881&rft_id=info:pmid/25784482&rfr_iscdi=true |